Merck | MRK - Ebitda

Stock Price
121.90
Daily Change
-1.10 -0.89%
Monthly
-1.02%
Yearly
-13.67%
Q1 Forecast
121.85

Merck reported EUR1.46B in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Adidas EUR 809M 83M Jun/2025
Adyen EUR 563.42M 142.82M Dec/2024
Akzo Nobel EUR 385M 8M Sep/2025
Alcon AG USD 654M 404M Sep/2025
Amadeus IT EUR 652.7M 5M Sep/2025
Amarin USD 12.54M 28.57M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
BASF EUR 1.54B 228M Sep/2025
Bayer EUR 1.51B 1.28B Sep/2025
Beiersdorf EUR 984M 147M Jun/2025
Covestro EUR 242M 24M Sep/2025
Danone EUR 2.45B 149M Jun/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 931.26M 60.26M Sep/2025
Galapagos EUR -158.71M 177.84M Mar/2025
Genmab DKK 477M 101M Sep/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Infineon EUR 1.2B 294M Sep/2025
Linde USD 3.38B 30M Sep/2025
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.46B 45M Jun/2025
Novartis USD 5.88B 290M Sep/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
UCB EUR 1.03B 334M Jun/2025